Open AccessA Phase Ib Dose‐finding Study of Panobinostat and Ruxolitinib in Myelofibrosis
Author(s) -
Harrison Claire,
Heidel Florian H.,
Vannucchi Alessandro M.,
Kiladjian JeanJacques,
Hayat Amjad,
Passamonti Francesco,
Conneally Eibhlin,
Kindler Thomas,
Martino Bruno,
Lipka Daniel B.,
Stefanelli Tommaso,
Roussou Pantelia,
Germano Davide,
Ewan Jacqueline,
Ribrag Vincent
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000757
Subject(s) - ruxolitinib , panobinostat , medicine , myelofibrosis , international prognostic scoring system , oncology , myeloproliferative neoplasm , bone marrow , myelodysplastic syndromes , histone deacetylase , biochemistry , gene , histone , chemistry